Pfizer-BioNTech said Thursday they will test a combined coronavirus and
influenza vaccine, which could potentially pave the way for better inoculation
uptake for both illnesses.
اضافة اعلان
The companies said in a statement the mRNA-based combination vaccine
candidate was set to progress to a phase one trial in the United States with
180 volunteers.
The inoculation "could simplify immunisation practices against these
two respiratory pathogens, potentially leading to better vaccine uptake for
both diseases," said Annaliesa Anderson, head of vaccine research and
development at US drugmaker Pfizer.
"Even with existing seasonal influenza vaccines, the burden of this
virus is severe across the world, causing thousands of deaths and
hospitalisations every year."
Pfizer and its German partner BioNTech developed one of the most widely used
vaccines to combat Covid-19.
Rival vaccine makers Moderna and Novavax have also been testing combined
inoculations against
Covid and flu.
Read More Lifestyle
Jordan News
.jpg)
.jpg)
